HOME >> MEDICINE >> NEWS
Laser measurements reveal biological basis of distance perception

Using a laser range-finder, neurobiologists have scanned real-life scenes to gather millions of distance measurements to surfaces in each scene -- analyzing the mass of data to explain a series of long-known but little-understood quirks in how people judge distances.

The measurements reveal, for example, that the tendency of people to estimate the distance of isolated objects as being six to 12 feet away arises because that is the average distance of actual objects and surfaces in the visual scenes people encounter.

Thus, said the Duke University Medical Center neurobiologists, the findings support their theory that the visual system has evolved to make the best statistical guess about distances and other features of visual scenes, based on past experience.

The researchers, Zhiyong Yang and Dale Purves, published their findings in the June 2003 issue of "Nature Neuroscience" (online version posted May 18, 2003). Their research was supported by the National Institutes of Health and the Geller Endowment. Yang is a postdoctoral fellow and Purves is the George B. Geller Professor for Research in Neurobiology.

"All the characteristics of the visual world that we take for granted -- for example the diminution of size with distance -- are a result of perception," said Purves. "So, a question for centuries has been, 'What is the biological reason we see space in the peculiar way that we do?'"

In their past research on the perception of the geometry, color, brightness and motion, Purves and his colleagues have accumulated evidence that visual processing is not the result of logical calculations about the image that falls on the retina of the eye as such. Rather, they have shown that vision is a fundamentally empirical phenomenon, in which the connections between nerve cells in the visual system evolved as a result of the success of organisms that correctly interpreted the inherently ambiguous visual world. Such ambiguity arises because the photons
'"/>

Contact: Dennis Meredith
dennis.meredith@duke.edu
919-681-8054
Duke University
20-May-2003


Page: 1 2 3

Related medicine news :

1. Laser surgery offers advantages for voice disorders
2. Laser method identifies, counts toxic molecules
3. Laser therapy offers hope for acne sufferers
4. Beckman Laser Institute to improve breast cancer detection
5. Laser technique able to detect developing cavities
6. Laser technology helps measure pollution from NYC buses
7. Laser research yields precision breath analysis tool for asthma diagnosis (treatment)
8. Laser procedure effective in correcting nasal blockages associated with deviated septum
9. Lasers light way to 3-D imaging in Purdue lab
10. Laser heart treatment shown to be safe and effective at lowering pain associated with heart disease
11. Laser Pointer Helps Parkinsons Patients Take Next Step

Post Your Comments:
(Date:1/22/2015)... January 23, 2015 LunaDress, with its top ... fashion industry. Now, the business is showing its latest designs ... dresses. , According to the company’s CEO, all the fresh ... offered with big discounts, up to 80% off. All the ...
(Date:1/22/2015)... January 22, 2015 Padre Murphy's and Owner ... of Pro Player Health Alliance (PPHA). The PPHA's ... in getting everyone, including NFL greats, treated for obstructive sleep ... leading groups supporting the cause in the valley. The most ...
(Date:1/22/2015)... January 22, 2015 Blue Cross and Blue ... who exemplify what it means to “Live Fearless.” ... people to share their stories about how they or someone ... inspired others by living in the moment. By telling these ...
(Date:1/22/2015)... A new white paper by The ... in the long-term care environment as well as provides ... The paper, “The Power of Person-Centeredness in Long-Term Care: ... of the patient, resident and family experience in long-term ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post ... insurance . , Purchasing an accidental death and dismemberment ... This type of rider provides benefits if the insured dies ... a lesser form of life insurance. , AD&D is ...
Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
(Date:1/23/2015)... , Jan. 23, 2015  Immune Therapeutics, Inc. today announced the ... the compounding, packaging and distributing of its naltrexone tablets.  The ... United States . KRS Global is ... tablets in various strengths for individual patients in response to ...
(Date:1/23/2015)... 23, 2015  HyGreen, Inc., a leader in hand hygiene ... RCA Medical, a subsidiary of Ascendis Health Limited, in ... Each year, hundreds of millions of patients around the ... are transmitted from patient to patient via the unwashed ...
(Date:1/23/2015)... 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that ... of Lixte,s lead compound, LB‑100, is being conducted, has been ... S. Kovach , M.D., the founder and President of Lixte, ... at a single site. Accrual of patients, however, was slower ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
Cached News: